Clinical Gynecologic Oncology
Expert Consult - Online and Print
By- Philip DiSaia, MD, The Dorothy Marsh Chair in Reproductive Biology, Professor, Department of Obstetrics and Gynecology, University of California, Irvine College of Medicine, Irvine, California, UCI Medical Center, Orange, California
- William Creasman, MD, Sims-Hester Professor and Chairman, Department of Obstetrics and Gynecology, Medical University of South Carolina, Charleston, SC
Clinical Gynecologic Oncology, by Drs. Di Saia and Creasman, is the leading medical reference book geared toward helping you improve gynecologic cancer outcomes. Youll see how to take advantage of the latest advances in early detection and improved treatment options for gynecologic cancers, especially uterine and cervical cancers, equipping you with the skills you need to provide effective and compassionate care for your patients.
Audience
OB/GYN
Hardbound, 720 Pages
Published: March 2012
Imprint: Mosby
ISBN: 978-0-323-07419-3
Contents
1. Preinvasive Disease of the Cervix
2. Preinvasive Disease of the Vagina and Vulva and Related Disorders
3. Invasive Cervical Cancer
4. Endometrial Hyperplasia, Estrogen Therapy, and the Prevention of Endometrial Cancer
5. Adenocarcinoma of the Uterine Corpus
6. Sarcoma of the Uterus
7. Gestational Trophoblastic Disease
8. Invasive Cancer of the Vulva
9. Invasive Cancer of the Vagina MAN
10. The Adnexal Mass
11. Epithelial Ovarian Cancer
12. Germ Cell, Stromal, and Other Ovarian Tumors
13. Fallopian Tube Cancer
14. Breast Diseases
15. Cancer in Pregnancy
16. Complications of Disease and Therapy
17. Basic Principles of Chemotherapy
18. Targeted Therapy and Molecular Genetics
19. Genes and Cancer: Genetic Counseling and Clinical Management
20. Palliative Care and Quality of Life Role of Minimally Invasive Surgery in Gynecologic Malignancies
22. Epidemiology of Commonly Used Statistical Terms and Analysis of Clinical Studies
23. Basic Principles in Gynecologic RadiotherapyAppendices
A. Staging
B. Modified from Common Terminology Criteria for Adverse Events (CTCAE)
C. Blood Component Therapy
D. Suggested Recommendations for Routine Cancer Screening
E. Nutritional Therapy
